Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation.
OBJECTIVE
We describe atypical motor and cognitive features in a case of familial Alzheimer disease (FAD) due to presenilin-1 (PS-1) mutation.


BACKGROUND
Extrapyramidal signs (EPS) typically are a late-presenting feature of sporadic Alzheimer disease (AD), but relatively little data are available regarding EPS in FAD.


METHODS
A 59-year-old, right-handed man of Caribbean-Hispanic descent underwent brain imaging studies, laboratory tests for AD, and serial neurologic and neuropsychologic evaluations.


RESULTS
The patient presented with recent-onset delusional ideation associated with cognitive decline. Prominent EPS developed soon after initiation of an atypical neuroleptic agent. Neuropsychologic evaluation revealed global cognitive deficits; he was found to be a carrier of a PS-1 point mutation at position G206A. EPS resolved completely after discontinuing the neuroleptic agent and coincided with improved motor speed, set initiation, and verbal fluency.


CONCLUSIONS
Severe neuroleptic sensitivity and associated deficits of cognitive speed occurred in response to a dopaminergic antagonist agent; both responded readily to withdrawal of the offending agent. Patients with PS-1 AD may be at substantially increased risk of neuroleptic-induced EPS. That feature underscores the heterogeneity of the FAD clinical phenotype.
Cercy
Steven P
SP
Memory Disorders Clinic, Veterans Affairs New York Harbor Healthcare System, New York, NY 10010, USA. steven.cercy@va.gov
Sadowski
Martin J
MJ
Wisniewski
Thomas
T
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D004252:DNA Mutational Analysis; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D017354:Point Mutation / Q000235:genetics*; D053764:Presenilin-1 / Q000235:genetics*
D014150:Antipsychotic Agents; D053764:Presenilin-1
Neurology. 2000 May 23;54(10):1965-71
10822438
Neurology. 2005 Jul 26;65(2):323-5
16043812
Int J Geriatr Psychiatry. 2002 Jul;17(7):649-51
12112163
J Pharmacol Exp Ther. 1988 Nov;247(2):661-70
2460616
Hum Mol Genet. 1998 Sep;7(9):1507-9
9700207
J Neurosci. 2007 Jun 6;27(23):6174-84
17553989
JAMA. 2001 Nov 14;286(18):2257-63
11710891
Acta Neuropathol. 2002 Dec;104(6):637-48
12410385
Psychiatry Res. 2002 Dec 30;116(3):163-72
12477600
Arch Neurol. 1998 Oct;55(10):1335-40
9779662
Neurology. 2005 Feb 8;64(3):509-13
15699383
Biol Psychiatry. 1998 Oct 15;44(8):765-74
9798081
J Neurosci. 1995 Jan;15(1 Pt 2):821-9
7823183
Am J Psychiatry. 1996 Apr;153(4):466-76
8599393
J Clin Psychopharmacol. 1999 Aug;19(4):322-8
10440459
Acta Neuropathol. 2000 Aug;100(2):145-52
10963361
J Neurol Sci. 2007 Sep 15;260(1-2):33-7
17459416
Brain Pathol. 2000 Jul;10(3):378-84
10885656
J Neurol Neurosurg Psychiatry. 2001 Dec;71(6):777-9
11723200
Lancet Neurol. 2003 Oct;2(10):605-13
14505582
Eur J Neurol. 2004 Oct;11(10):663-9
15469450
Ann Neurol. 2005 Mar;57(3):429-34
15732120
J Clin Psychiatry. 2005 May;66(5):633-7
15889951
Brain. 2000 May;123 ( Pt 5):894-907
10775535
Mayo Clin Proc. 1999 Aug;74(8):835-7
10473363
Brain. 1999 Aug;122 ( Pt 8):1449-68
10430831
Am J Geriatr Psychiatry. 2000 Summer;8(3):226-31
10910421
J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):796-8
16705205
J Geriatr Psychiatry Neurol. 2006 Dec;19(4):195-201
17085757
Neuropsychopharmacology. 2004 Jun;29(6):1190-202
15010698
Neurology. 2003 May 27;60(10):1586-90
12771246
Neurology. 2005 Dec 27;65(12):1863-72
16237129
Psychopharmacology (Berl). 2007 May;191(4):1027-9
17333131
Arch Neurol. 2001 Mar;58(3):466-72
11255451
J Clin Psychopharmacol. 2006 Apr;26(2):192-7
16633151
Neuropsychopharmacology. 2007 Jan;32(1):171-9
16841077
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):103-8
12551731
Neurology. 1994 Dec;44(12):2300-7
7991116
Lancet. 1998 Apr 4;351(9108):1032-3
9546516
Arch Neurol. 2003 Jun;60(6):884-8
12810495